ArticleJournal of applied genetics2016

Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.

Aleksandra Majchrzak-Celińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.